Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zenabis Global Inc. T.ZENA

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space.


TSX:ZENA - Post by User

Zenabis Global Inc. > Sundial
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(53)
•••
Comment by Canuck30on Jan 03, 2021 12:56am
161 Views
Post# 32210819

RE:RE:RE:RE:RE:RE:Sundial

RE:RE:RE:RE:RE:RE:Sundial

It's a shrewd investment by Sundial. They're getting a phenomenal return on their investment and if Zenabis falters on payment, they basically take over operations which includes properties. Not bad IMO for $50 million. Alternatively, to buy out Zenabis, they would have to pay a premium to the current price plus take on the $120 million+ debt. They're basically saving over $40 million if Zenabis falters and Sundial takes everything. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities